Hyperprolactinemia

Pituitary

Volumn 11, Issue 2, 2008, Pages 141-146

  Chahal, Jaspreet ^a   Schlechte, Janet ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Hook effect; Macroprolactin; Pituitary tumor; Prolactin

Indexed keywords

CARBIDOPA; CHLORPROMAZINE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; INSULIN; LEVODOPA; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NOMIFENSINE; ORAL CONTRACEPTIVE AGENT; PROLACTIN; PROTIRELIN; PSYCHOTROPIC AGENT; RISPERIDONE; THYROID HORMONE;

ARTICLE; ARTIFACT REDUCTION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; DRUG WITHDRAWAL; GEL FILTRATION CHROMATOGRAPHY; HEALTH CARE COST; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSECTOMY; HYPOPHYSIS ADENOMA; HYPOTHYROIDISM; IMMUNORADIOMETRIC ASSAY; INCIDENCE; KIDNEY FAILURE; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROLACTINOMA; PROTIRELIN TEST; PULSATILE HORMONE RELEASE; RADIOIMMUNOASSAY; RELIABILITY; TUMOR VOLUME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERPROLACTINEMIA; PITUITARY FUNCTION TESTS; PITUITARY NEOPLASMS; PROLACTIN;

EID: 43049179853     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0107-5     Document Type: Article

References (60)

1. Parker DC, Rossman LG, Vanderlaan EF (1973) Relation of sleep-entrained human prolactin release to REM-NonREM cycles. J Clin Endocrinol Metab 38:646-65132
2. Sassin JF, Frantz AG, Kapen S, Weitzman ED (1973) The nocturnal rise of human prolactin is dependent upon sleep. J Clin Endocrinol Metab 37:436-440. Medline
3. Veldhuis JD, Johnson L (1988) Operating characteristics of the hypothalamo-pituitary-gonadal axis in men; circadian, ultradian and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 67:116-123. Medline
4. Quigley ME, Ropert JF (1981) Acute prolactin, release triggered by feeding. J Clin Endocrinol Metab 52:1043-1045. Medline
5. Carlson HE, Hyman DB, Blitzer MG (1990) Evidence for an intracerebral action of phenylalanine in stimulation of prolactin secretion: interaction of large neutral amino acid. J Clin Endocrinol Metab 70:814-816. Medline
6. Lee PA, Xenakis T, Winer J et al (1976) Puberty in girls: Correlation of serum levels of gonadotropins, prolactin, androgens, estrogens and progestins with physical changes. J Clin Endocrinol Metab 43:775-784. Medline
7. Blackman MR (1987) Pituitary hormones and aging. Endocrinol Clin N Am 16:981-984
8. Iranmesh A, Mulligan T, Veldhuis JD (1998) Mechanism subserving the physiological nocturnal hypoprolactinemia of healthy older men: Dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency and interpulse interval - a general clinical research study. J Clin Endocrinol Metab 999:1083-1090
9. Vekeman M, Delvoye P, L'Hermite M et al (1977) Serum prolactin levels during the menstrual cycle. J Clin Endocrinol Metab 44:989-993. Medline
10. Neilly AS, Chard T (1974) Circulating levels of prolactin during the menstrual cycle. Clin Endocrinol (Oxf) 3:105-112. Medline
11. Tyson JE, Fresen HG (1973) Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women. Am J Obstet Gynecol 116:377-387. Medline
12. Reyniak JV, Wenof M, Aubert JM et al (1980) Incidence of hyperprolactinemia during oral contraceptive therapy. Obstet Gynecol 55:8-11. Medline
13. Davis JR, Selby C, Jeffcoate WJ (1984) Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol (Oxf) 20:427-434. Medline
14. Urban RJ (1992) Neuroendocrinology of aging in the male and female. Endocrinol Metab Clin North Am 21:921-931. Medline
15. Reyes FI, Winter JS, Faiman C (1977) Pituitary-ovarian relationships preceding the menopause. A cross-sectional study of serum follicle-stimulated hormone, luteinizing hormone, prolactin, oestradiol and progesterone levels. Am J Obstet Gynecol 129:557-564. Medline
16. Karunakaran S, Page RCL, Wass JAH (2001) The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 54:295-300. Medline. doi: 10.1046/j.1365-2265.2001.01190.x
17. Touraine P, Deneux C, Plu-Bureau G et al (1998) Hormonal replacement therapy in menopausal women with history of hyperprolactinemia. J Endocrinol Invest 21:732-736. Medline
18. Schlegel W, Petersdorf LI, Junker R et al (1999) The effects of six months of treatment with a low dose of conjugated oestrogens in menopausal women. Clin Endocrinol (Oxf) 51:643-651. Medline. doi: 10.1046/j.1365-2265.1999.00857.x
19. Bonnar J, Franklin M, Nott PN et al (1975) Effect of breast-feeding on pituitary-ovarian function after childbirth. BMJ 4:82-84. Medline
20. Van den Berge G, de Zegher F, Bouillon R (1998) Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83:1827-1834. Medline. doi: 10.1210/jc.83.6.1827
21. Jarrell J, Franks S, McInnes R et al (1980) Breast examination does not elevate serum prolactin. Fertil Steril 33:49-51. Medline
22. Casanueva FF, Molitch ME, Schlechte JA et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265-273. Medline. doi: 10.1111/ j.1365-2265.2006.02562.x
23. Muneyyirci DO, Goldstein D, Reyes FI (1989) Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test. N Y State J Med 89:205-208. Medline
24. Moli RL, Endert E, Fliers E et al (2003) Evaluation of endocrine tests. A: The TRH test in patients with hyperprolactinaemia. Neth J Med 71:44-48
25. Sawers HA, Robb OJ, Walmsley D (1997) An audit of the diagnostic usefulness of prolactin and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia. Clin Endocrinol (Oxf) 46:321-326. Medline. doi: 10.1046/j.1365-2265.1997.1350956.x
26. Kamoi T, Tchuchida I, Sata H et al (1981) Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors. J Clin Endocrinol Metab 53:1285-1287. Medline
27. Archer DF, Josimovich JB, Maroon JC (1977) Chlorpromazine-induced changes in serum prolactin in women with oligomenorrhea, amenorrhea and pituitary adenoma. Fertil Steril 28:1164-1167. Medline
28. Tucker HG, Lankford HV, Gardner DF et al (1980) Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with galactorrhea-amenorrhea syndrome. J Clin Endocrinol Metab 51:968-971. Medline
29. Cowden EA, Thomsom JA, Doyle D et al (1979) Tests of prolactin secretion in diagnosis of prolactinomas. Lancet 320:1155-1158. doi: 10.1016/ S0140-6736(79)91841-5
30. Molitch ME, Goodman RH, Post KD et al (1982) Surgical cure of prolactinoma reverses abnormal prolactin response to carbidopa/l-dopa. J Clin Endocrinol Metab 55:1118-1123. Medline
31. Vance ML, Thorner MO (1987) Prolactinomas. Endocrinol Metab Clinics N Amer 16:731-753
32. St-Jean E, Blain F, Comtois R (1996) High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 44:305-309. Medline. doi: 10.1046/ j.1365-2265.1996.663486.x
33. Suh HK, Frantz AG (1974) Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 39:928-935. Medline
34. Farkouh NH, Packer MG, Frantz AG (1979) Large molecular size prolactin with reduced receptor activity in human serum: High proportion in basal state and reduction after thyrotropin-releasing hormone. J Clin Endocrinol Metab 48:1026-1032. Medline
35. Hattori N, Inagaki C (1997) Anti-prolactin autoantibodies cause asymptomatic hyperprolactinemia: Bioassay and clearance studies of prolactin-immunoglobulin G complex. J Clin Endocrinol Metab 82:3107-3110. Medline. doi: 10.1210/jc.82.9.3107
36. Fahie-Wilson M, Soule S (1997) Macroprolactinaemia: Contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 34:252-258, Medline
37. Olukoga A, Kane J (1999) Macroprolactinaemia: Validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 51:119-126. Medline. doi: 10.1046/j.1365-2265.1999.00757.x
38. Leslie H, Courtney C, Bell P et al (2001) A Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86:2743-2746. Medline. doi: 10.1210/jc.86.6.2743
39. Vallette-Kasic S, Morange-Ramos I, Selim A et al (2002) Macroprolactinemia revisited: A study on 106 patients. J Clin Endocrinol Metab 587:581-588. doi: 10.1210/jc.87.2.581
40. Suliman AM, Smith TP, Gibney J et al (2003) Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: Application of a new strict laboratory definition of macroprolactinemia. Clin Chem 49:1504-1509. Medline. doi: 10.1373/49.9.1504
41. Molitch ME, Russell EJ (1990) The pituitary 'incidentaloma'. Ann Intern Med 112:925-931. Medline
42. Smith TP, Suliman AM, Fahie-Wilson MN et al (2002) Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87:5410-5415. Medline. doi: 10.1210/jc.2001-011943
43. Pinto LP, Hanna FWF, Evans LM, Davies JS, John R, Scanlon MF (2003) The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia. Clin Endocrinol (Oxf) 59:580-584. Medline. doi: 10.1046/ j.1365-2265.2003.01887.x
44. Gibney J, Smith TP, McKenna TJ (2005) The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 90:3927-3932. Medline. doi: 10.1210/jc.2004-2234
45. David SR, Taylor CC, Kinon BJ (2000) The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther 22:1085-1096. Medline. doi: 10.1016/ S0149-2918(00)80086-7
46. Molitch M (2005) Medication-induced hyperprolactinemia. Mayo Clin Proc 80:1050-1057 Medline
47. Lim VS, Kathpalia S, Frohman LA (1979) Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: Reversal after transplantation. J Clin Endocrinol Metab 48:101-107 Medline
48. Honbo KS, Herle AJV, Kellett KA (1978) Serum prolactin levels in untreated primary hypothyroidism. Am J Med 64:782-787. Medline. doi: 10.1016/0002-9343(78)90517-X
49. Frank S (1995) Polycystic ovary syndrome. N Engl J Med 333:853-861. Medline. doi: 10.1056/NEJM199509283331307
50. Hilho RB, Domingues L, Naves L, Ferraz E, Alves A, Casulari LA (2007) Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol 23:267-272. Medline. doi: 10.1080/09513590701297708
51. Morgan MY, Jakobovits AW, Gore MB et al (1978) Serum prolactin in liver disease and its relationship to gynecomastia. Gut 19:170-174. Medline. doi: 10.1136/gut.19.3.170
52. Serri O, Chik CL, Ur E et al (2003) Diagnosis and management of hyperprolactinemia. CMAJ 169:575-581. Medline
53. Schlechte JA (2003) Prolactinoma. N Engl J Med 349:2035-2041. Medline. doi: 10.1056/NEJMcp025334
54. Arafah MB, Nekl KE, Gold RS et al (1995) Dynamics of prolactin secretion in patients with hypopituitarism and pituitary macroadenomas. J Clin Endocrinol Metab 80:3507-3512. Medline. doi: 10.1210/jc.80.12.3507
55. Karavitaki Ni Thanabalasingham G, Shore HCA, Trifanescu R, Ansorge O, Meston N, Turner H, Wass JAH (2006) Do the limits of serum prolactin in disconnection hyperprolactinemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 65:524-529. Medline. doi: 10.1111/ j.1365-2265.2006.02627.x
56. Schlechte J, Dolan K, Sherman B et al (1989) The natural history of untreated hyperprolactinemia; a prospective analysis. J Clin Endocrinol Metab 68:412-418. Medline
57. Verhelst J, Abs R (2003) Hyperprolactinemia: Pathophysiology and management. Treat Endocrinol 2:23-32. Medline. doi: 10.2165/ 00024677-200302010-00003
58. Kauppila A, Chatelaiin P, Kirkinen P (1987) Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab 64:309-312. Medline
59. Saito T, Tojo K, Sakamoto N et al (2007) A case of prolactin deficiency with familial puerperal alactogenesis accompanying impaired ACTH secretion. Endocr J 54:59-62. Medline. doi: 10.1507/endocrj.K05-163
60. Toledano Y, Lubetsky A, Shimon I (2007) Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest 30:268-273. Medline